50 seizures daily: Doctors tell teenager she would not survive to become an adult; check what happens next
Megan Dixon went to the hospital for some tests. She was discharged after two years.
The teenager, who started feeling sick at 13, was eventually diagnosed with Functional Neurological Disorder (FND) at 16. She was left completely paralysed after a hospital stay meant for tests.
Once unable to walk, talk or open her eyes, she had to spend two years in care. Now, she's preparing to move into her own home in Peterborough. She hopes of becoming a nail technician and rebuilding her life.
At 18, Megan moved to a care centre far from her family for treatment. She felt alone and vulnerable. Paralysed and unable to speak or see, she recalled how hard it was, especially for her parents.
She was diagnosed with FND, which disrupted signals between her brain and body. At her worst, she had 50 seizures daily.
She couldn't speak, see or swallow. She was tube-fed and fully dependent on others. Now, seizures have reduced to 10–15 a day.
"It was not easy. I think it was a lot harder for my mum and dad to have to leave me there on my own, but I couldn't do anything for myself. I was paralysed from the neck down," Megan told the BBC.
Her life has completely changed after 18 months of therapy. Though she can't walk due to knee contractions, she can now move, talk and see.
Once told she might not survive, she's now 20.
"I was getting to the point that I nearly died in hospital, my body just shut down that much. The doctors did have to tell my parents to prepare for the worst - they didn't think I would make it to 18 and here I am at 20," she told the publication.
As she is saving for a course, Meghan looks forward to living with her boyfriend.
First Published: 24 Apr 2025, 05:02 PM IST
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
19 hours ago
- News18
WTA Introduces Rankings Protect Rule For Players Undergoing Fertility Treatments
Last Updated: The WTA Tour will protect the rankings of women tennis players taking breaks for egg or embryo freezing. The WTA Tour announced on Wednesday that women tennis players taking a break from competition to undergo egg or embryo freezing will have their rankings protected. Players ranked between 1 and 750 in singles or doubles who are absent from competition for at least 10 consecutive weeks for a 'fertility preservation procedure" qualify for this protection. This special ranking can be used for entry into up to three tournaments, excluding Premier 1000 events. The protected ranking will be calculated based on the player's average WTA ranking over a 12-week period, starting eight weeks prior to the commencement of their break. 2017 US Open champion, Sloane Stephens, told the BBC that this rule change would alleviate pressure on players to return to competition prematurely. Stephens revealed she had previously utilised the off-season twice for egg freezing. In the WTA statement, the 32-year-old expressed pride in the sport's recognition of the importance of fertility treatments for female athletes. She acknowledged the nuanced and complex discussion surrounding career and family life, highlighting the WTA's creation of a supportive environment for players to explore their options and make informed decisions. The WTA stated that the 'Fertility Preservation Special Entry Ranking Rule" would augment existing benefits, assisting players in balancing their tennis careers and family aspirations. WTA CEO, Portia Archer, acknowledged the potential dilemma faced by professional athletes regarding career and family. She reaffirmed the WTA's dedication to supporting players as they navigate these important life choices. First Published: June 11, 2025, 21:49 IST
Hindustan Times
20 hours ago
- Hindustan Times
WTA gives ranking protection for players who freeze eggs
Women tennis players who take time out of the game to freeze eggs or embryos will have their ranking protected, the WTA Tour announced on Wednesday. Players ranked from one to 750 in singles or doubles who spend at least 10 consecutive weeks out of competition for a "fertility protection procedure" are eligible. The ranking can be used to enter up to three tournaments but the policy does not apply to the premier 1000 events. The special ranking will be based on the 12-week average of a player's WTA ranking from eight weeks prior to the start of their out-of-competition period. Sloane Stephens, the 2017 US Open champion, told the BBC the rule will reduce the pressure on players to return to the court too quickly. Stephens said she had twice previously used the off-season to freeze her eggs. The 32-year-old said in the WTA statement that she was "incredibly proud of our sport in recognising the importance of fertility treatments for female athletes". "For any woman, the conversation of family life versus a career is nuanced and complex," she said. "The WTA has now created a safe space for players to explore options and to make the best decisions for themselves." The WTA said in a statement that the "Fertility Protection Special Entry Ranking Rule" would enhance the existing package of benefits to help players combine family life with tennis. WTA CEO Portia Archer said: "We understand that professional athletes can face a dilemma between focusing on their career and starting a family, and we are committed to supporting WTA players as they navigate and balance the choices associated with career and family." In March the WTA and Saudi Arabia's Public Investment Fund announced the introduction of a maternity fund programme, giving players paid maternity leave for up to 12 months and access to grants for fertility treatments. The PIF is a global partner of the WTA Tour. jw/kca/mw
NDTV
3 days ago
- NDTV
Nitazene: All About Drug That's Upto 500 Times Stronger Than Heroin
A drug, believed to be 50-500 times more effective than heroin, has become a major cause of concern in London, UK. Authorities have issued a warning over the deadly synthetic opioid named Nitazene, which is gaining popularity among partygoers. The drug, which is apparently similar to fentanyl, is suspected to be the reason behind two recent deaths, the BBC reported, adding that even tiny doses can be fatal. The Metropolitan Police said that an investigation is underway into the "sudden deaths" of a 28-year-old man and a 20-year-old woman in Southall on May 26. "This is following reports that the individuals allegedly passed away after taking an illicit substance in the form of a green pill," a spokesperson for the force said as quoted by the BBC. The Loop, a UK-based drug testing charity, said that the pills contain synthetic opioids called Nitazenes. The pills can be "50 to 500 times stronger than heroin", and they look like oxycodone pills (oxys). In an Instagram post, East London nightclub The Cause said that the pills had caused "several hospitalisations across multiple London venues". What are nitazenes? Nitazenes were developed in the 1950s as pain-relieving agents. BBC reported that these drugs suppress the respiratory system, hence, people die as they stop breathing. The report also noted that a person can be saved by taking naloxone, which is an antidote. There have been at least 18 deaths linked to nitazenes in London from May 2023 to June 2024, as per the most recent government data. The European Union Drugs Agency (EUDA) in a recent report highlighted rapid shifts in Europe's drug market. The report noted that this trend has created new health and security risks. As per EUDA, a total of 88 new synthetic opioids have appeared on the European market since 2009. All of the seven new synthetic opioids formally notified to the EWS were nitazenes in 2024. A total of 22 nitazenes are being monitored in Europe to date in Europe. "A recent EUDA pilot threat assessment, focusing on new synthetic opioids in the Baltics, found that nitazenes accounted for a significant share of overdose deaths in Estonia and Latvia. In 2024, at least seven EU Member States and Norway reported harms linked to nitazenes," the EUDA report read.
